Stockreport

Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Atreca, Inc.  (BCEL) 
Last atreca, inc. earnings: 3/11 04:30 pm Check Earnings Report
PDF REDWOOD CITY, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on [Read more]